Malaria Prophylaxis Guidelines

Regional Considerations for Prophylaxis

The British Medical Association recommends chloroquine (300 mg base weekly) as the first-line prophylactic medication for travel to areas without chloroquine-resistant P. falciparum, such as parts of Central America west of the Panama Canal 3
For areas with limited to moderate chloroquine resistance, the World Health Organization suggests chloroquine (300 mg base weekly) combined with proguanil (200 mg daily) provides substantial protection 1
In areas with high chloroquine resistance, the Centers for Disease Control and Prevention recommend mefloquine as a first-line option, with a dosage of one 250 mg tablet weekly for adults 1
The American Society of Tropical Medicine and Hygiene recommends doxycycline as a first-line alternative in areas with mefloquine-resistant falciparum malaria, particularly in East Asia 2

The World Health Organization notes that mefloquine is effective against chloroquine-resistant P. falciparum but associated with neuropsychiatric side effects, and is contraindicated in those with a history of convulsions, epilepsy, or serious psychiatric disorders 1
The Centers for Disease Control and Prevention recommend doxycycline as an alternative regimen for travelers to areas with chloroquine-resistant P. falciparum, but note it is not recommended for children under 8 years, pregnant women, or lactating mothers 2

The British Medical Association emphasizes that compliance is essential, as most malaria deaths occur in travelers who do not fully comply with prophylaxis regimens, and recommends starting prophylaxis 1-2 weeks before travel (except atovaquone-proguanil which can be started 1-2 days before) 1, 2
The American Society of Tropical Medicine and Hygiene suggests using insect repellents containing DEET on exposed skin, wearing long-sleeved clothing and long trousers if outdoors after sunset, and using pyrethrum-containing flying-insect spray in living and sleeping areas 1, 2

The World Health Organization notes that no prophylactic regimen guarantees 100% protection against malaria, and that P. vivax and P. ovale can cause relapsing malaria due to persistent liver stages (hypnozoites) that can remain dormant for up to 4 years 3, 4
The Centers for Disease Control and Prevention emphasize that prompt medical evaluation is essential if symptoms develop, as delayed treatment can have serious or fatal consequences, and that malaria prophylaxis should be selected based on the specific travel destination, duration of stay, and individual patient factors 1, 2, 3